Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States. Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists. Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications…
| Price | $27.15 |
|---|---|
| Market cap | $2.13B |
| Sector | Healthcare |
| Industry | Medical - Healthcare Plans |
| Exchange | NASDAQ |
| 52-week range | 16.1-33.065 |
| Beta | 0.99 |
Explore PGNY's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.